Bone marrow and plasma FGF‐23 in heart failure patients: novel insights into the heart

Bone marrow and plasma FGF‐23 in heart failure patients: novel insights into the heart–bone axis

Published:2019-03-25 Issue:3 Volume:6 Page:536-544
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Jeinsen Beatrice¹²³,Sopova Kateryna¹³,Palapies Lars¹,Leistner David M.¹⁴⁵,Fichtlscherer Stephan¹³,Seeger Florian H.¹³,Honold Jörg¹³,Dimmeler Stefanie⁶³,Aßmus Birgit¹³,Zeiher Andreas M.¹³,Keller Till¹²³^ORCID

Affiliation:

1. Division of Cardiology, Department of Internal Medicine IIIGoethe University Frankfurt Frankfurt Germany

2. Department of CardiologyKerckhoff Heart and Thorax Center Benekestr. 2‐8 61231 Bad Nauheim Germany

3. German Centre for Cardiovascular Research (DZHK), partner site RheinMain Frankfurt Germany

4. Campus Benjamin Franklin, Department of CardiologyCharité – Universitaetsmedizin Berlin Berlin Germany

5. German Centre for Cardiovascular Research (DZHK), partner site Berlin Berlin Germany

6. Institute for Cardiovascular RegenerationGoethe University Frankfurt Frankfurt Germany

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.12416

Reference30 articles.

1. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

2. How Fibroblast Growth Factor 23 Works

3. Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active

4. Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

5. Fibroblast growth factor 23: associations with cardiovascular disease and mortality in chronic kidney disease

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Klotho protein, fibroblast growth factor 23, and sclerostin in chronic heart failure: literature review;CardioSomatics;2024-04-10

2. FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF;Scientific Reports;2023-09-25

3. Baseline fibroblast growth factor 23 is associated with long-term mortality in ST-elevation myocardial infarction—results from the augsburg myocardial infarction registry;Frontiers in Cardiovascular Medicine;2023-08-04

4. FGF23 and klotho at the intersection of kidney and cardiovascular disease;Nature Reviews Cardiology;2023-07-13

5. FGF-23 is a Biomarker of RV Dysfunction and Congestion in Patients with HFrEF;2023-04-18